SEP 11, 2026 · PHASE 3 TRIAL
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
ClinicalTrials.gov
This is an ongoing Phase 3 trial with no results reported; the registry record describes only planned enrollment, design, and primary outcome measures.
Reported
Planned enrollment1100
Treatment duration76 weeks
Primary outcome measurePercent change in body weight from Baseline…